The two emerging models of patient centricity in healthcare: patient outreach and engagement, are being redefined by technology and data explosion. The proliferation of data-driven systems and technological advances including wearable tech is enabling more personalized patient outreach initiatives. Just take #Microsoft'𝘀 𝗿𝗲𝗰𝗲𝗻𝘁 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗗𝗼𝗰𝘁𝗼𝗿 𝗮𝗻𝗱 𝗖𝗹𝗶𝗻𝗶𝗰 𝗔𝗱𝘀, which aims to help healthcare professionals reach targeted patient segments in a revolutionary way.

1. Are we ready for the next-gen phase of patient marketing in healthcare?
The two emerging models of patient centricity in healthcare: patient outreach and engagement, are being redefined by technology and data
explosion.
The proliferation of data-driven systems and technological advances including wearable tech is enabling more personalized patient outreach
initiatives. Just take #Microsoft'𝘀 𝗿𝗲𝗰𝗲𝗻𝘁 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗗𝗼𝗰𝘁𝗼𝗿 𝗮𝗻𝗱 𝗖𝗹𝗶𝗻𝗶𝗰 𝗔𝗱𝘀, which aims to help healthcare professionals reach
targeted patient segments in a revolutionary way.
The value proposition of patient engagement among healthcare institutions is also evolving, as it goes beyond mere appointment scheduling
applications. This is all on the back of AI-driven software solutions and #Preventivehealthcare, aiming to design customized programs for high-
risk populations. The global market for preventive healthcare alone is expected to cross $𝟱𝟬𝟬 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 by as early as 𝟮𝟬𝟯𝟬.
Healthcare marketing, as a domain, has long battled with issues like data privacy in achieving widespread implementation of AI/ML-based
targeted marketing, but players are now innovating with novel technologies like digital engagements and remote monitoring through solutions
devised on consent and compensation.
AI-driven 𝗠𝗮𝗿𝗧𝗲𝗰𝗵 (𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆) portfolios are actively being built by numerous leading healthcare providers, all in hopes to
revolutionize the patient journey as we know it.
Read on as Jasper Colin explores the dynamic landscape of hyper-targeted marketing with perspectives from leading healthcare institutions
and global technology vendors of incidental sectors.

2. Hyper-Targeting
Patients:
Are we ready for the next-
gen phase in marketing?
The of technology, data, and
consumerism in healthcare is re-shaping our
approach to patients.
holy-trifecta
Data to Decision

3. Direct-to-Patient Model to
create Value for patients
Moving beyond mere targeted
advertising, healthcare
institutions are increasingly
experimenting with a
to
address patient needs in the
most focused manner to
enhance adoption.
personalized approach
Data to Decision

4. Tailoring a DTP Strategy for Hypertargeting
Communication:
Jasper Colin’s Medi-Insights
72% of medical professionals
2030.
research reported that
believe hyper-
targeted brand communication will become the
norm by
Onboarding:
Therapy programs and financial assistance for
disease based segments through niche channels
are driving marketing strategies much before
patient onboarding.
Delivery:
User-centered engagement platforms and digital
tools are considered by
in healthcare.
‘essentials for hospitals’
81% of consultants
1
2
3
Data to Decision

5. Mapping the care journey as per Jasper Colin’s expert panel
transcripts with
revealed the continuum of needs throughout
the patient journey.
This includes three core stages:
80+ healthcare consultants and marketing
specialists
Pre-Seeking Stage: Pre-Treatment
Treatment Information Dissemination and Accessibility
Proactive Interaction and engagement platforms
Treatment En-route
Emotional Response Channels
Acute Care Innovation
Re-engagement: Post-Treatment
Continual Communication & feedback loops
Community Partnerships
Data to Decision

6. “
of engagement in healthcare is going to be essential in the
journey of improving Patient Reported Outcomes (PROs) in
the coming days”
Unraveling the ongoing crisis
cost perspective: hyper-targeted “value”
Hyper-targeted healthcare is in demand for better cost models as
well. has been an issue in the
space for a long time.
found that,
Higher cost of prescription therapies
Jasper Colin
Data to Decision
chronic patients in the US are
with costly therapies,
dissatisfied
and about of them identify
as a leading cause of their
dissatisfaction.
Demand for “hyper-targeted-value” is on the rise.
50% cost of physician
and care interactions
high
50%

7. Jasper Colin Engagement Toolkit for
“the quality imperative” in healthcare
The strategic ecosystem
catering to the patient
needs throughout the
engagement cycle starts
with
and continues (but
certainly doesn’t end) with
the
.
Some of the leading
efforts of Jasper Colin in
this field:
patient enrolment &
information dissemination
care engagement
programs
and more...
04
Clinical Decision
Support
01
Patient
Programs
02
Modeling
Based
Segmentation
03
Remote
Digital
Monitoring
Get in touch today for more insights /sales@jaspercolin.com